派林生物：接受国泰基金等投资者调研

Group 1 - The core viewpoint of the news is that Palin Biotech (SZ 000403) is engaging with investors through a scheduled research meeting from December 16 to 24, 2025, where the company’s board secretary, Zhao Yulin, will address investor inquiries [1] - As of the latest report, Palin Biotech's market capitalization stands at 13.3 billion yuan [3] - The revenue composition for Palin Biotech in the first half of 2025 indicates that the pharmaceutical industry accounts for 99.95% of its total revenue, while other businesses contribute only 0.05% [2]